Editorial: COVID-19 and hematological malignancies: Volume II

Front Oncol. 2022 Oct 10:12:1044582. doi: 10.3389/fonc.2022.1044582. eCollection 2022.

Authors

Lindsay Wilde¹, Adam Binder¹, Claudio Cerchione², Alessandro Isidori³

Affiliations

¹ Department of Medical Oncology, Division of Hematologic Malignancy and Stem Cell Transplantation, Thomas Jefferson University Hospital, Philadelphia, PA, United States.
² Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
³ Hematology and Stem Cell Transplant Center, Azienda Ospedaliera Ospedaliera Ospedali Riuniti Marche Nord (AORMN) Hospital, Pesaro, Italy.

No abstract available

Keywords: COVID - 19; leukemia; lymphoma; myeloproliferative neoplasms; plasma cell dyscrasia.

Publication types

Editorial